- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: lenalidomide (Revlimid)
Total 1146 results
-
Ohio State University Comprehensive Cancer CenterMorphoSys AGActive, not recruitingRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage III Small Lymphocytic Lymphoma | Stage IV Small Lymphocytic Lymphoma | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Contiguous Stage II Small Lymphocytic... and other conditionsUnited States
-
Peking Union Medical College HospitalHenan Cancer Hospital; Shengjing Hospital; Sun Yat-Sen Memorial Hospital of Sun... and other collaboratorsNot yet recruitingGestational Trophoblastic NeoplasiaChina
-
Maria LiljeforsKarolinska University Hospital; Karolinska Institutet; CelgeneCompletedPancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma MetastaticSweden
-
M.D. Anderson Cancer CenterGenentech, Inc.; CelgeneCompleted
-
Sellas Life Sciences GroupUnknownMultiple Myeloma | Minimal Residual Disease | High-Risk CancerUnited States
-
iOMEDICO AGAmgenActive, not recruiting
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
Arbeitsgemeinschaft medikamentoese TumortherapieMerck Sharp & Dohme LLC; Celgene CorporationTerminatedPeripheral T-Cell Non-Hodgkin's LymphomaAustria
-
David Rizzieri, MDGenzyme, a Sanofi Company; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
Gesellschaft fur Medizinische Innovation - Hamatologie...Completed
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential ThrombocythemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene; Aduro Biotech, Inc.Active, not recruitingMultiple MyelomaUnited States
-
Masonic Cancer Center, University of MinnesotaCelgene CorporationTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
German CLL Study GroupRoche Pharma AG; Celgene; Mundipharma Research GmbH & Co KGCompletedChronic Lymphocytic LeukemiaGermany
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingFatigue | Weight Loss | Fever | Splenomegaly | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1... and other conditionsUnited States
-
University of LeedsKaryopharm Therapeutics Inc; Myeloma UKWithdrawnMyeloma MultipleUnited Kingdom
-
CelgeneCompleted
-
Leap Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityAstraZeneca; Celgene CorporationActive, not recruitingMantle Cell LymphomaUnited States
-
CelgeneCompleted
-
CelgeneThe Lymphoma Academic Research OrganisationCompletedFollicular LymphomaJapan, United States
-
National Cancer Institute (NCI)Active, not recruitingAnemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | de Novo Myelodysplastic SyndromeUnited States
-
City of Hope Medical CenterTerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AG; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellAustria
-
Northwestern UniversityNational Cancer Institute (NCI); CelgeneActive, not recruitingPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous... and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterNovartis; CelgeneCompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin Lymphoma | Adult Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Fondazione EMN Italy OnlusActive, not recruitingMultiple Myeloma | New Diagnosis TumorItaly
-
CelgeneCompleted
-
Dong-A University HospitalAmgenNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Peking Union Medical College HospitalCelgene CorporationCompleted
-
University College, LondonCancer Research UK; CelgeneActive, not recruitingPlasmacytomaUnited Kingdom
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
CelgeneCompleted
-
Landspitali University HospitalMemorial Sloan Kettering Cancer Center; Celgene; Amgen; University of IcelandEnrolling by invitationMultiple Myeloma | Smoldering Multiple MyelomaIceland
-
Massachusetts General HospitalCompletedMultiple MyelomaUnited States
-
Bristol-Myers SquibbExelixisCompletedAdvanced Cancer, Various, NOSUnited States
-
Istituto Nazionale Tumori IRCCS - Fondazione G....UnknownRecurrent Adult Hodgkin LymphomaItaly
-
Irene Ghobrial, MDJanssen Research & Development, LLCRecruitingMultiple Myeloma | Smoldering Multiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
University of ChicagoActive, not recruitingMultiple MyelomaUnited States, Poland
-
Cancer Trials IrelandCompleted
-
Duke UniversityMillennium Pharmaceuticals, Inc.; Duke Cancer InstituteTerminated
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
IRCCS Centro di Riferimento Oncologico della BasilicataCelgene CorporationCompleted
-
The Lymphoma Academic Research OrganisationCelgene CorporationActive, not recruitingFollicular LymphomaSpain, Canada, France, Australia, Italy, Belgium, Germany, Portugal
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory... and other conditionsUnited States